BioCentury
ARTICLE | Clinical News

Cobas HPV test regulatory update

December 3, 2012 8:00 AM UTC

Roche said its cobas 4800 HPV test received CE Mark approval as a primary screen to identify women at highest risk for cervical cancer. The pharma said a co- or pre-test with pap cytology is no longer...